Immune Activation Repurposed for Developing Hepatitis C Therapy

[Guest guest]

Immune Activation Repurposed for Developing Hepatitis C Therapy

Medical chemists from the UK are working on an oral Hepatitis C drug that works by activating a protein in the immune system.

New hepatitis C drug

14 February 2011

Scientists in the UK have developed a compound to combat the hepatitis C virus that could be taken as a pill.

Pryde and his team from Pfizer Global Research and Development, Sandwich, have made new compounds to activate a protein in the immune system called TLR7 - toll-like receptor 7 - which fights the infection. Toll-like receptors identify foreign DNA, such as a virus, and produce proteins that inhibit the virus' replication.

Continue reading this entire article:http://www.rsc.org/chemistryworld/News/2011/February/14021101.asp

http://www.hepatitis-central.com/mt/archives/2011/02/immune_activati.html